Výsledky vyhledávání - "Ryoko Shimada‐Omori"

Body mass index, HbA1c and serum C-reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital-based retrospective case-control study

Autor: Masayuki Asano, Setsuya Aiba, Akiko Hagiwara-Takita, Kenshi Yamasaki, Toshiya Takahashi, Yoshiyuki Kusakari, Ryoko Shimada-Omori, Kenichiro Tsuchiyama, Mei Nasu-Tamabuchi, Hitoshi Terui, Tomoyuki Ohtani

Publikováno v: The Journal of dermatologyREFERENCES. 48(11)

Biologics has had a great impact on psoriasis treatment as well as the life of psoriasis patients. Infliximab (IFX), one of the biologics targeting tumor necrosis factor (TNF), is the first of the biologics introduced to Japanese psoriasis patients.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5e01ce5b53ee0a84a84bd783b2aa0dc
https://pubmed.ncbi.nlm.nih.gov/34355429

Zobrazit plný text záznamu

Pediatric psoriasis induced by HLA-B46-Cw1 haplotype: A retrospective study of psoriasis onset after hematopoietic stem cell transplantation

Autor: Hitoshi Terui, Setsuya Aiba, Akiko Hagiwara-Takita, Kenshi Yamasaki, Yuka Saito-Nanjo, Ryoko Shimada-Omori, Kenichiro Tsuchiyama, Takeshi Rikiishi, Yoji Sasahara

Publikováno v: The Journal of dermatologyREFERENCES. 48(9)

Genome-wide association studies have identified more than 60 susceptibility loci for psoriasis, highlighting the role of genetics in psoriasis development. Although the HLA region is suggested as the most prominent susceptibility locus, the role of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b135b5dabfbe501c113f0abb7ef346
https://pubmed.ncbi.nlm.nih.gov/33960525

Zobrazit plný text záznamu

TLR3 augments glucocorticoid-synthetic enzymes expression in epidermal keratinocytes; Implications of glucocorticoid metabolism in rosacea epidermis

Autor: Setsuya Aiba, Takeshi Yamauchi, Ryoko Shimada-Omori, Saaya Koike, Kenshi Yamasaki

Publikováno v: Journal of dermatological science. 100(1)

Background While most skin diseases benefit from topical steroids, rosacea symptoms are exacerbated by topical steroids. In the rosacea pathogenesis, abnormal innate immune mechanisms including overexpression of the Toll-like receptor (TLR) have been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a840130c87cc1b3cf44a3bd5864c2a34
https://pubmed.ncbi.nlm.nih.gov/32888783

Zobrazit plný text záznamu

Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failure

Autor: Setsuya Aiba, Kenichiro Tsuchiyama, Yoshiyuki Kusakari, Ryoko Shimada-Omori, Kenshi Yamasaki, Toshiya Takahashi, Mei Nasu-Tamabuchi

Publikováno v: The Journal of Dermatology. 42:727-730

The efficacy and safety of biologic treatments have been established in patients with moderate to severe psoriasis, but there are few reports on biologic therapy for patients with psoriasis complicated by end-stage renal failure on hemodialysis (HD).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a41a93d1210376f9d3d53d12abab191
https://doi.org/10.1111/1346-8138.12901

Zobrazit plný text záznamu

Therapeutic drug monitoring of patients with psoriasis during tumour necrosis factor (TNF)-α antagonist treatment using a novel interleukin-8 reporter cell line

Autor: Kenichiro Tsuchiyama, Setsuya Aiba, Kenshi Yamasaki, Toshiya Takahashi, Rika Nishikawa, Ryoko Shimada-Omori, Yutaka Kimura, Chikako Nishigori, Yoshiyuki Kusakari

Publikováno v: The British journal of dermatology. 175(5)

SummaryBackground Tumour necrosis factor (TNF)-α antagonist therapy is currently used for moderate and severe psoriasis. However, this treatment has several drawbacks, including interindividual variability in clinical response and secondary loss of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a860b2defe5d87d42c04f30b7e3fd9f2
https://pubmed.ncbi.nlm.nih.gov/27790684

Zobrazit plný text záznamu

Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes

Autor: Sawako Fukushi-Takahashi, Rumiko Saito, Setsuya Aiba, Masayuki Asano, Ryoko Shimada-Omori, Kenshi Yamasaki, Na Li

Publikováno v: Journal of immunology (Baltimore, Md. : 1950). 193(10)

Several dermatoses, including psoriasis, atopic dermatitis, and rosacea, alter the expression of the innate immune effector human cathelicidin antimicrobial peptide (CAMP). To elucidate the roles of aberrant CAMP in dermatoses, we performed cDNA arra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5068d8b4c6864b33882d4678548c52b3
https://pubmed.ncbi.nlm.nih.gov/25305315

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání